Get to know our clinical trials

Ensayo clínico para la continuación del tratamiento del estudio y el seguimiento de la seguridad.

CLINICAL TRIAL FOR CONTINUATION OF STUDY TREATMENT AND SAFETY MONITORING.

Imagen de la Dra. Ana Alfonso Piérola, especialista en Hematología de la Clínica Universidad de Navarra. La Dra. Alfonso se dedica al estudio y tratamiento de los síndromes mielodisplásicos y las leucemias mieloblásticas agudas.
Dr. Ana Alfonso Piérola [SP] Curriculum
Specialist Hematology and Hemotherapy Department
Navarre headquarters
Madrid headquarters
Cancer Center
Hematologic Cancer Area
Status
In recruitment
headquarters
Pamplona

Technical Summary

  • CLINICAL STUDY FOR CONTINUATION OF STUDY TREATMENT AND SAFETY MONITORING.
  • Code EudraCT: 2024-515457-21
  • Protocol number: PLATFORMPACAN1001
  • Promoter: Janssen Cilag SA
  • Molecule/Drug: JNJ-74856665
  • Link to Clinical Trials

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial

I want to make an appointment
Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.

I WANT TO REQUEST A SECOND OPINION